{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:42:17Z","timestamp":1786171337557,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Orthop Surg Traumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pseudomyogenic hemangioendothelioma is rare, usually indolent vascular tumor characterized immunohistochemically by SERPINE1-FOSB fusion, presenting as multiple bone and soft tissue lesions, affecting males in their 3rd\u20134th decades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present the case of a 28-years-old male patient with the history of pain in the left lower extremity hindering him in the daily activities. Radiological examinations showed well-defined lytic lesions of the femur, patella, tibia, fibula, talus and calcaneus with low metabolic activity on PET-scan. MR revealed multiple soft tissue involvements of the affected extremity. Multiple skin lesions were located on the extensor surface of the leg. Molecular analysis confirmed the pathognomonic gene fusion. Patient was treated with epirubicin as an eight-cycle locoregional intraarterial monotherapy, achieving clinical control of the disease and substantial improvement in complaints for over 10\u00a0years. The patient\u2019s complaints decreased substantially, his bony lesions, however, are persisting for over ten years of his follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The molecular characteristics and differential diagnostics of the disease is well known, however, due to the rarity of the disease, the wide array of treatment methods and short-term follow-up intervals, there is still no consensus over the most efficient treatment plan. Many chemotherapeutic agents and treatment regimens were utilized throughout the literature, with acceptable outcomes as far as reported but self-limiting character and spontaneous regression of the disease have also been described according to our experience during the very long follow-up period of our patient.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00590-026-04917-5","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:04Z","timestamp":1786167784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pseudomyogenic hemangioendothelioma (involving skin, bone and soft tissue): a case report with long-term follow-up and review of literature"],"prefix":"10.1007","volume":"36","author":[{"given":"Maysam","family":"Moghaddam Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1kos","family":"S\u00fck\u00f6sd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Antal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"S\u00e1pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"P\u00e1pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Szendr\u0151i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"issue":"6","key":"4917_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.5858\/arpa.2017-0430-RS","volume":"143","author":"A Al-Qaderi","year":"2019","unstructured":"Al-Qaderi A, Mansour AT (2019) Pseudomyogenic hemangioendothelioma. Arch Pathol Lab Med 143(6):763\u2013767. https:\/\/doi.org\/10.5858\/arpa.2017-0430-RS","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"4917_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PAS.0b013e3181ff0901","volume":"35","author":"JL Hornick","year":"2011","unstructured":"Hornick JL, Fletcher CDM (2011) Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Am J Surg Pathol 35(2):190\u2013201. https:\/\/doi.org\/10.1097\/PAS.0b013e3181ff0901","journal-title":"Am J Surg Pathol"},{"key":"4917_CR3","volume-title":"Soft tissue and bone tumours WHO classification of tumours editorial board: Cristina R. Antonescu and 14 others","year":"2020","unstructured":"Antonescu CR (ed) (2020) Soft tissue and bone tumours WHO classification of tumours editorial board: Cristina R. Antonescu and 14 others. International Agency for Research on Cancer"},{"issue":"10","key":"4917_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.radcr.2019.06.029","volume":"14","author":"S Dianat","year":"2019","unstructured":"Dianat S, Yousaf H, Murugan P, Marette S (2019) Pseudomyogenic hemangioendothelioma\u2014a case report and review of the literature. Radiol Case Rep 14(10):1228\u20131232. https:\/\/doi.org\/10.1016\/j.radcr.2019.06.029","journal-title":"Radiol Case Rep"},{"key":"4917_CR5","volume-title":"Diagnosis and treatment of malignant soft tissue tumors [HUN]","year":"2017","unstructured":"Szendr\u0151i M, S\u00e1pi Z, P\u00e1pai Z (eds) (2017) Diagnosis and treatment of malignant soft tissue tumors [HUN]. Medicina K\u00f6nyvkiad\u00f3"},{"issue":"6","key":"4917_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/1097-0142(19920315)69:6<1382::aid-cncr2820690614>3.0.co;2-y","volume":"69","author":"JM Mirra","year":"1992","unstructured":"Mirra JM, Kessler S, Bhuta S, Eckardt J (1992) The fibroma-like variant of epithelioid sarcoma. A fibrohistiocytic\/myoid cell lesion often confused with benign and malignant spindle cell tumors. Cancer 69(6):1382\u20131395. https:\/\/doi.org\/10.1002\/1097-0142(19920315)69:6%3c1382::aid-cncr2820690614%3e3.0.co;2-y","journal-title":"Cancer"},{"issue":"1","key":"4917_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00000478-200301000-00006","volume":"27","author":"SD Billings","year":"2003","unstructured":"Billings SD, Folpe AL, Weiss SW (2003) Epithelioid sarcoma-like hemangioendothelioma. Am J Surg Pathol 27(1):48\u201357. https:\/\/doi.org\/10.1097\/00000478-200301000-00006","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"4917_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5858\/arpa.2018-0395-RS","volume":"144","author":"GA Caballero","year":"2020","unstructured":"Caballero GA, Roitman PD (2020) Pseudomyogenic hemangioendothelioma (epithelioid sarcoma-like hemangioendothelioma). Arch Pathol Lab Med 144(4):529\u20135333. https:\/\/doi.org\/10.5858\/arpa.2018-0395-RS","journal-title":"Arch Pathol Lab Med"},{"key":"4917_CR9","unstructured":"Fletcher C, Bridge J, Hogendoorn P, Mertens F (2013) WHO classification of tumours of soft tissue and bone: WHO classification of tumours, vol. 5, 4th edn. World Health Organization"},{"issue":"4","key":"4917_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cancergen.2011.01.002","volume":"204","author":"D Trombetta","year":"2011","unstructured":"Trombetta D, Magnusson L, von Steyern FV, Hornick JL, Fletcher CDM, Mertens F (2011) Translocation t(7;19)(q22;q13)\u2014a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma? Cancer Genet 204(4):211\u2013215. https:\/\/doi.org\/10.1016\/j.cancergen.2011.01.002","journal-title":"Cancer Genet"},{"issue":"4","key":"4917_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jos.2017.02.004","volume":"22","author":"S Sugita","year":"2017","unstructured":"Sugita S, Hasegawa T (2017) Practical use and utility of fluorescence in situ hybridization in the pathological diagnosis of soft tissue and bone tumors. J Orthop Sci 22(4):601\u2013612. https:\/\/doi.org\/10.1016\/j.jos.2017.02.004","journal-title":"J Orthop Sci"},{"issue":"5","key":"4917_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","volume":"41","author":"YP Hung","year":"2017","unstructured":"Hung YP, Fletcher CDM, Hornick JL (2017) FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma. Am J Surg Pathol 41(5):596\u2013606. https:\/\/doi.org\/10.1097\/PAS.0000000000000795","journal-title":"Am J Surg Pathol"},{"key":"4917_CR13","doi-asserted-by":"crossref","unstructured":"Doyle LA, Fletcher CDM, Hornick JL (2015) Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics. www.ajsp.com","DOI":"10.1097\/PAS.0000000000000511"},{"issue":"6","key":"4917_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/his.12713","volume":"67","author":"R Shibuya","year":"2015","unstructured":"Shibuya R, Matsuyama A, Shiba E, Harada H, Yabuki K, Hisaoka M (2015) CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67(6):827\u2013835. https:\/\/doi.org\/10.1111\/his.12713","journal-title":"Histopathology"},{"issue":"3","key":"4917_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.22037","volume":"107","author":"SAHJ De Visscher","year":"2006","unstructured":"De Visscher SAHJ, Van Ginkel RJ, Wobbes T, Veth RPH, Ten Heuvel SE, Suurmeijer AJH, Hoekstra HJ (2006) Epithelioid sarcoma: still an only surgically curable disease. Cancer 107(3):606\u2013612. https:\/\/doi.org\/10.1002\/cncr.22037","journal-title":"Cancer"},{"issue":"5","key":"4917_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/PAS.0000000000000613","volume":"40","author":"A Inyang","year":"2016","unstructured":"Inyang A, Mertens F, Puls F, Sumathi V, Inwards C, Folpe A, Lee C-H, Zhang Y, Symmans P, Rubin B, Nielsen GP, Nguyen V-H, Rosenberg AE (2016) Primary pseudomyogenic hemangioendothelioma of bone. Am J Surg Pathol 40(5):587\u2013598. https:\/\/doi.org\/10.1097\/PAS.0000000000000613","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4917_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00256-015-2168-7","volume":"44","author":"AR Shah","year":"2015","unstructured":"Shah AR, Fernando M, Musson R, Kotnis N (2015) An aggressive case of pseudomyogenic haemangioendothelioma of bone with pathological fracture and rapidly progressive pulmonary metastatic disease: case report and review of the literature. Skeletal Radiol 44(9):1381\u20131386. https:\/\/doi.org\/10.1007\/s00256-015-2168-7","journal-title":"Skeletal Radiol"},{"issue":"7","key":"4917_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/RLU.0000000000000800","volume":"40","author":"M Bryanton","year":"2015","unstructured":"Bryanton M, Makis W (2015) Pseudomyogenic hemangioendothelioma mimicking multiple myeloma on 18F-FDG PET\/CT, followed by spontaneous regression. Clin Nucl Med 40(7):579\u2013581. https:\/\/doi.org\/10.1097\/RLU.0000000000000800","journal-title":"Clin Nucl Med"},{"issue":"1","key":"4917_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00256-022-04109-2","volume":"52","author":"J Maximen","year":"2023","unstructured":"Maximen J, Christory A, Bonneau-Lagacherie J, Guillin R, Ropars M (2023) Spontaneously regressive multifocal bone pseudomyogenic hemangioendothelioma in a 17-year-old boy: a case report. Skeletal Radiol 52(1):119\u2013127. https:\/\/doi.org\/10.1007\/s00256-022-04109-2","journal-title":"Skeletal Radiol"},{"key":"4917_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6072-8","author":"S Otani","year":"2019","unstructured":"Otani S, Nakayama R, Sekita T, Hirozane T, Asano N, Nishimoto K, Sasaki A, Okita H, Morioka H, Nakamura M, Matsumoto M (2019) Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-019-6072-8","journal-title":"BMC Cancer"},{"issue":"3","key":"4917_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4103\/jcrt.JCRT_1138_20","volume":"18","author":"S Pasricha","year":"2022","unstructured":"Pasricha S, Sharma A, Pruthi M, Durga G, Jajodia A, Gupta G, Kamboj M, Gupta M, Mehta A (2022) Multifocal primary pseudomyogenic hemangioendothelioma of bone managed with denosumab: a rare case with diagnostic and therapeutic challenge. J Cancer Res Ther 18(3):817\u2013819. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1138_20","journal-title":"J Cancer Res Ther"},{"key":"4917_CR22","doi-asserted-by":"publisher","unstructured":"Brance ML, C\u00f3ccaro NM, Roitman P, Castiglioni A, Agostinis F, Spense M, Scheitlin B, Rene N, Brun LR (2022) Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature. In: Archives of osteoporosis, vol. 17, Number 1. Springer Science and Business Media Deutschland GmbH. https:\/\/doi.org\/10.1007\/s11657-022-01062-4","DOI":"10.1007\/s11657-022-01062-4"},{"issue":"2","key":"4917_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/2311-3006.346409","volume":"9","author":"DD-R Huang","year":"2022","unstructured":"Huang DD-R, Liao Y-H, Lee J-C, Chen TW-W (2022) Total metabolic regression after everolimus in an adult patient with pseudomyogenic hemangioendothelioma. J Cancer Res Pract 9(2):65\u201368. https:\/\/doi.org\/10.4103\/2311-3006.346409","journal-title":"J Cancer Res Pract"},{"issue":"6","key":"4917_CR24","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/MPH.0000000000000778","volume":"39","author":"M Ozeki","year":"2017","unstructured":"Ozeki M, Nozawa A, Kanda K, Hori T, Nagano A, Shimada A, Miyazaki T, Fukao T (2017) Everolimus for treatment of pseudomyogenic hemangioendothelioma. J Pediatr Hematol Oncol 39(6):e328\u2013e331. https:\/\/doi.org\/10.1097\/MPH.0000000000000778","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"4917_CR25","doi-asserted-by":"publisher","first-page":"e26781","DOI":"10.1002\/pbc.26781","volume":"65","author":"KM Gabor","year":"2018","unstructured":"Gabor KM, Sapi Z, Tiszlavicz LG, Fige A, Bereczki C, Bartyik K (2018) Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatr Blood Cancer 65(2):e26781. https:\/\/doi.org\/10.1002\/pbc.26781","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"4917_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/MPH.0000000000001459","volume":"41","author":"OM Danforth","year":"2019","unstructured":"Danforth OM, Tamulonis K, Vavra K, Oh C, Brickman A, Ebersole J, Cameron J, Mahon B, Kent P (2019) Effective use of sirolimus and zoledronic acid for multiosteotic pseudomyogenic hemangioendothelioma of the bone in a child: case report and review of literature. J Pediatr Hematol Oncol 41(5):382\u2013387. https:\/\/doi.org\/10.1097\/MPH.0000000000001459","journal-title":"J Pediatr Hematol Oncol"},{"key":"4917_CR27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25250","author":"A Alhanash","year":"2022","unstructured":"Alhanash A, Aseafan M, Atallah J (2022) Pazopanib as treatment option for pseudomyogenic hemangioendothelioma: a case report. Cureus. https:\/\/doi.org\/10.7759\/cureus.25250","journal-title":"Cureus"},{"issue":"11","key":"4917_CR28","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1158\/1078-0432.CCR-17-3512","volume":"24","author":"DGP VanJzendoorn","year":"2018","unstructured":"VanJzendoorn DGP, Sleijfer S, Gelderblom H, Eskens FALM, Van Leenders GJLH, Szuhai K, Bovee JVMG (2018) Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma. Clin Cancer Res 24(11):2678\u20132687. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3512","journal-title":"Clin Cancer Res"},{"key":"4917_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14376-6","author":"Q Cai","year":"2025","unstructured":"Cai Q, Xu B, Zhang P, Ma J, Liang J, Le L, Li S, Yang J, Pan Q, Peng R, Zhang X (2025) The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-025-14376-6","journal-title":"BMC Cancer"},{"issue":"7","key":"4917_CR30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00256-014-2089-x","volume":"44","author":"AT Davis","year":"2015","unstructured":"Davis AT, Guo AM, Phillips NJ, Greenberg DD (2015) A novel treatment for bone lesions of multifocal epithelioid sarcoma-like hemangioendothelioma. Skeletal Radiol 44(7):1013\u20131019. https:\/\/doi.org\/10.1007\/s00256-014-2089-x","journal-title":"Skeletal Radiol"}],"container-title":["European Journal of Orthopaedic Surgery &amp; Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00590-026-04917-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00590-026-04917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T05:43:06Z","timestamp":1786167786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00590-026-04917-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4917"],"URL":"https:\/\/doi.org\/10.1007\/s00590-026-04917-5","relation":{},"ISSN":["1432-1068"],"issn-type":[{"value":"1432-1068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they do not have any conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. According to institutional policy, written informed consent was obtained from the patient for the use of anonymised data for scientific research and publication.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain any individual person\u2019s data in any form. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"330"}}